Sherry Layton, Vetanco USA Inc. CSO, was invited to give a presentation at Vaccines 2020

Published 28/07/2020 in category News

Due to the rising interest in Biotech Vac. Technology, Sherry Layton, Chief Scientific Officer of Vetanco USA, was invited to develop the subject: “Reducing The Use Of Antimicrobials Through Innovative Universal Subunit Vaccine Platform Design.”


Covid-19, with a high impact on biotechnology professionals, is currently an urgent priority. Vaccines 2020 will bring together the global industry’s key leaders to discuss the latest ideas and developments in this field. This meeting platform will facilitate networking, learning and interaction in this crucial moment. For a global audience, Vaccines 2020 will bring together professionals from the most important pharmaceutical and biotechnology laboratories and research organizations in order to offer cutting-edge content.

Leave your comment

18 − nine =

View all news